FindTrial
Sign In

A study on vancomycin resistant enterococci bacteria in a tertiary care hospital.

A study on vancomycin resistant enterococci among the various clinical samples in a tertiary care hospital. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100977
Enrollment
139
Registered
2026-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R895- Abnormal microbiological findingsin specimens from other organs, systems and tissues Health Condition 2: R898- Other abnormal findings in specimens from other organs, systems and tissues

Interventions

Intervention1: Nil: Nil

Sponsors

Yashesvi Rai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients admitted with suspected infection in the tertiary care hospital during the study period. 2.Pregnant women. 3.Immunocompromised patients. 4.Patients with catheter. 5.All samples from OPD/IPD from the clinical departments.

Exclusion criteria

Exclusion criteria: 1.All other bacterial, viral, fungal, parasitic growth. 2.Patients who refuse to give consent.

Design outcomes

Primary

MeasureTime frame
To determine the resistance profile and pattern of vancomycin resistant enterococciTimepoint: 16 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactYashesvi Rai

Vinayaka Missions Kirupananda Variyar Medical College and Hospital

drmathavimicro@gmail.com9600251333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026